Higher rates of cervical cancer amongst immigrants

	Tweet

Gynaecological screening tests for cervical cancer have been available to all women in Sweden for almost four decades. Despite this, many immigrant women have a higher risk of developing the disease than Swedish-born women, according to a new study from Karolinska Institutet.

This is particularly the case for women from other Nordic countries and Central America, the differences being linked to, amongst other things, variation in the incidence of the Human Pappiloma Virus (HPV) around the world. HPV is a significant risk factor for cervical cancer.

“But there are other risk factors too, such as smoking, sexual habits and not taking screening tests, which make it interesting to compare cervical cancer rates between different groups of immigrant women in Sweden and native Swedes,” says Professor Pär Sparén, who has led the study at the Department of Medical epidemiology and Biostatistics. 

The study included more than 750,000 resident immigrant women from different countries, all of whom are registered on Karolinska Institutets national database of womens health. During the period under study (1968 to 2004) there were 1,991 cases of cervical cancer in this group. Compared with Swedish-born women in general, this represents a slightly higher risk of developing the disease (10 per cent). Also, the incidence proportion of cervical cancer amongst women who had immigrated to Sweden was lower than amongst women in their respective countries.

However, the study also shows wide variation between the immigrant groups. Women from east Africa generally were five times less likely to develop cervical cancer than Swedish-born women, while women from southern Asia were half as likely. Conversely, the risk was much higher for women from Norway and Denmark (70 per cent and 80 per cent, respectively) and Central America (150 per cent).

Professor Sparéns team also observed that the risk of cervical cancer increased with the age of entry into Sweden, but declined during their period of residency in their new homeland. Professor Sparén believes that his findings are important for the more effective prevention of cervical cancer through, for example, targeted screening programmes.

“We need to introduce targeted screening for the prevention of cervical cancer amongst high-risk groups, particularly women over 50 during their first ten years in Sweden,” he says.

The study, which was funded with a grant from the Swedish Council for Working Life and Social Research (FAS) and the National Health Care Sciences Postgraduate School at Karolinska Institutet, was a joint project with Tehran University of Medical Sciences in Iran and Mälardalen University.
Publication:

Fatima Azerkan, Kazem Zendehdel, Per Tillgren, Elisabeth Faxelid and Pär Sparén
Risk of cervical cancer among immigrants by age at immigration and follow-up time in Sweden, from 1968 to 2004

International Journal of Cancer, 3 September 2008

Professor Pär Sparén

Work:  +46 (0)8-524 861 02
Mobile: +46 (0)70-794 46 74

E-mail:

PhD Student Fatima Azerkan

Work:  +46 (0)08-524 82 289
Mobile: +46 (0)73-7358157

E-mail:

Press Officer Katarina Sternudd

Work: +46 (0)8-524 838 95
Mobile: +46 (0)70-2243895

E-mail:

RELATED STORIES:
Staging of cervical cancer complicating pregnancy   Gates backs cervical cancer vaccines for poor   A Cervical Cancer Screening Month Resolution   Aggressive vaccine effort could cut cervical cancer   Stress May Increase a Woman’s Risk of Developing Cervical Cancer   Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types   Cervical cancer vaccines may cut need for screening   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Protein found to be the link missing between HPV infection and cervical cancer development   Cervical cancer screening rates low in poor areas   Fewer than 3 doses of cervical cancer vaccine effective   Post-treatment PET Scans Can Reassure Cervical Cancer Patients   Merck’s cervical cancer vaccine on sale in Europe   IUDs almost halve risk of cervical cancer: study   HPV Vaccine Reduces Abnormal Pap Test Results   Glaxo HPV vaccine shows promise for women 26-55   How Medical Center Research Led to New Cervical Cancer Vaccine   The Pill doesn’t affect cervical pre-cancer risk   Adding test for cervical cancer raises costs: study   Newer cervical cancer test no better than the old?   HPV tests better for cervical screening - experts   “Screen and treat” cervical cancer programs effective in poorly resourced areas

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]